
Shares of medical supply firm Medline MDLN.O down 3.7% at $39.50 premarket a day after strong Nasdaq debut
Stock surged 41% on Wednesday; having opened at $35 vs $29 IPO price, giving co around $46 bln valuation in the largest U.S. IPO since Rivian's RIVN.O 2021 listing
MDLN announced selling about 216 mln shares, above its plans to offer 179 mln shares, at upper end of $26-$30 range for deal size of about $6.3 bln
Co said it plans to use proceeds to repay term loan debt and redeem equity interests from pre-IPO owners, per statement